Prosight Management, LP - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 85 filers reported holding UROGEN PHARMA LTD in Q3 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2020$2,608,000
-64.1%
146,179
-32.8%
1.22%
-61.8%
Q4 2019$7,264,000
-6.3%
217,686
-33.1%
3.19%
-25.9%
Q3 2019$7,754,000
-17.3%
325,385
+24.7%
4.30%
-9.0%
Q2 2019$9,378,000
+60.8%
260,928
+65.3%
4.73%
+85.3%
Q1 2019$5,831,000157,8622.55%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,111,050$9,099,0004.23%
GREAT POINT PARTNERS LLC 873,424$7,153,0001.72%
Wildcat Capital Management, LLC 533,139$4,366,0001.45%
Opaleye Management Inc. 238,670$1,955,0000.88%
MENORA MIVTACHIM HOLDINGS LTD. 2,949,489$24,156,0000.44%
Annandale Capital, LLC 84,331$691,0000.27%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$206,0000.18%
RTW INVESTMENTS, LP 857,464$7,023,0000.18%
Harel Insurance Investments & Financial Services Ltd. 1,025,611$8,400,0000.18%
BENDER ROBERT & ASSOCIATES 41,131$337,0000.13%
View complete list of UROGEN PHARMA LTD shareholders